Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Brain Res ; 737(1-2): 221-30, 1996 Oct 21.
Artigo em Inglês | MEDLINE | ID: mdl-8930369

RESUMO

The effects of a single dexfenfluramine (D-fen) administration on the release of endogenous serotonin (5-hydroxytryptamine, 5-HT), excitatory (glutamate, Glu, aspartate, Asp) and inhibitory (gamma-aminobutyric acid, GABA) amino acids from the frontal cortex were studied by using in vivo microdialysis in freely-moving rats. Extracellular levels of these neurotransmitters were measured with HPLC coupled to electrochemical detection or with capillary electrophoresis coupled to laser-induced fluoresence detection (CE-LIFD). In a first study, single intraperitoneal administration of D-fen (0.5, 1.3, 5 and 10 mg/kg) increased extracellular 5-HT levels in a dose-dependent manner (maximal increase by 982% over baseline for the highest dose) while changes in Glu, Asp or GABA never reached statistical significance. In a second study, 73 nM of D-fen applied locally through the frontocortical dialysis probe, at a flow rate of 1.5 microliters/min in 30 microliters of perfusion fluid for 20 min, increased extracellular 5-HT and Asp levels [the maximal increases were to 1804% and 280% of the respective basal values (100%)] without altering extracellular levels of Glu and GABA. Thus, the order of magnitude of the changes induced by systemic administration or local infusion of D-fen on frontocortical extracellular levels of several neurotransmitters (5-HT > > Asp > GABA = Glu) demonstrate that D-fen, an indirect serotoninergic agonist, mainly increases 5-HT release while producing slight (Asp) or no (Glu, GABA) short-term in vivo variations in amino acid extracellular levels in the rat frontal cortex.


Assuntos
Aminoácidos Excitatórios/metabolismo , Fenfluramina/farmacologia , Lobo Frontal/efeitos dos fármacos , Serotoninérgicos/farmacologia , Serotonina/metabolismo , Ácido gama-Aminobutírico/metabolismo , Animais , Ácido Aspártico/metabolismo , Estado de Consciência , Relação Dose-Resposta a Droga , Eletroforese Capilar , Espaço Extracelular/metabolismo , Corantes Fluorescentes , Lobo Frontal/metabolismo , Ácido Glutâmico/metabolismo , Ácido Hidroxi-Indolacético/metabolismo , Injeções Intraperitoneais , Lasers , Masculino , Microdiálise , Ratos , Ratos Sprague-Dawley
2.
Biochem Pharmacol ; 44(10): 2082-5, 1992 Nov 17.
Artigo em Inglês | MEDLINE | ID: mdl-1449526

RESUMO

We investigated potential competition between L-tryptophan (TRP) and 6-fluoro-DL-tryptophan (6-F-TRP) for binding to albumin and for passage through the blood-brain barrier (BBB). In experiments based on equilibrium dialysis, albumin (600 microM) bound about 80% of TRP and 50% of 6-F-TRP with affinity constants (Ka) of 3.7 +/- 0.04 x 10(4) and 0.62 +/- 0.01 x 10(4) M-1, respectively. Competitive inhibition was assessed as the decrease in the apparent Ka (K' a) of TRP in the presence of 6-F-TRP, with no modification of the N value. Competition between TRP, 6-F-TRP and L-valine (VAL) for passage across the BBB was demonstrated using two approaches. When administered concomitantly with TRP or 6-F-TRP to rats, VAL decreased brain uptake of TRP and 6-F-TRP and reversed their action on serotonin. In Oldendorf's model, 6-F-TRP and VAL decreased the brain uptake of TRP.


Assuntos
Química Encefálica , Albumina Sérica/metabolismo , Triptofano/análogos & derivados , Triptofano/metabolismo , Animais , Ligação Competitiva , Barreira Hematoencefálica , Córtex Cerebral/metabolismo , Hipotálamo/metabolismo , Masculino , Ratos , Ratos Wistar , Soroalbumina Bovina/metabolismo , Valina/metabolismo
3.
Fundam Clin Pharmacol ; 5(6): 497-502, 1991.
Artigo em Inglês | MEDLINE | ID: mdl-1720112

RESUMO

The time course of 5-hydroxytryptophan (5-HTP), serotonin (5-HT), and 5-hydroxyindoleacetic acid (5-HIAA) concentrations in four rat brain areas (hypothalamus, hippocampus, striatum and olfactory bulbs) were investigated after treatment with L-dopa (125 mg/kg, ip) + benserazide (50 mg/kg, ip). 5-HTP levels increased as early as 0.5 h, showed maximum accumulation at 1.5 h and returned to control levels within 4 h, while 5-HT was markedly decreased in all four structures, with a maximum effect at 1.5 h (approximately -70%) in the four areas. The decrease in 5-HT was not accompanied by changes in 5-HIAA levels. In agreement with previous studies, these data demonstrate that L-dopa loading interferes with serotonin metabolism in the rat brain. However, in addition to the releasing action of newly-synthesized dopamine, the accumulation of 5-HTP and the parallel decrease in 5-HT indicate a reduction in 5-HT synthesis. This inhibition could be explained by a competitive effect of L-dopa for aromatic aminoacid decarboxylase activity.


Assuntos
5-Hidroxitriptofano/metabolismo , Encéfalo/metabolismo , Ácido Hidroxi-Indolacético/metabolismo , Levodopa/farmacologia , Serotonina/metabolismo , Animais , Benserazida/farmacologia , Encéfalo/efeitos dos fármacos , Corpo Estriado/metabolismo , Descarboxilação , Hipocampo/metabolismo , Hipotálamo/metabolismo , Masculino , Bulbo Olfatório/metabolismo , Ratos , Ratos Endogâmicos
4.
Brain Res Bull ; 22(3): 531-5, 1989 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-2713725

RESUMO

Absolute levels and ratio of serotonergic compounds in food-related hypothalamic nuclei were determined with a chromatographic method comparing for control (C) versus lean (L) versus obese (O) rats. In all three groups, a second parameter, i.e., fasting (F) versus satiation (S) was superimposed on the body weight factor. Indoleamine levels failed to show statistical differences depending on the body weight and/or the nutritional status. A significant negative correlation between an index of the serotonin turnover, the 5-HIAA/5-HT ratio, and body weight was found for the paraventricular (PVN) nucleus in the C and L groups as well as for the lateral (LH) nucleus for the C and O groups. A positive correlation was found for the ventromedian (VMH) nucleus in the O group. These data suggest that the body weight factor is implicated in the central serotonergic regulation more than the feeding parameter.


Assuntos
Peso Corporal , Comportamento Alimentar/fisiologia , Hipotálamo/metabolismo , Obesidade/metabolismo , Serotonina/metabolismo , Animais , Feminino , Hipotálamo/fisiologia , Hipotálamo/fisiopatologia , Ratos , Ratos Endogâmicos
5.
Magnes Res ; 1(3-4): 163-7, 1988 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-3275203

RESUMO

Spontaneously hypertensive rats (SHR) received a highly magnesium enriched diet during the development of hypertension, which caused plasma Mg concentrations to be markedly increased. Arterial blood pressure was reduced in supplemented animals. Levels of noradrenaline, 3-dihydroxyphenylacetic acid and homovanillic acid in cortex, hypothalamus, striatum and brain stem remained unchanged. Dopamine levels in the cortex, hypothalamus and striatum were also unchanged. Dopamine levels in brain stem increased. However the correlation between treatment with magnesium, dopamine-related variables in the brain and decrease in blood pressure in SHR remains hypothetical.


Assuntos
Encéfalo/metabolismo , Catecolaminas/metabolismo , Hipertensão/metabolismo , Magnésio/farmacologia , Ácido 3,4-Di-Hidroxifenilacético/metabolismo , Animais , Encéfalo/efeitos dos fármacos , Dieta , Dopamina/metabolismo , Ácido Homovanílico/metabolismo , Magnésio/administração & dosagem , Magnésio/sangue , Masculino , Norepinefrina/metabolismo , Ratos , Ratos Endogâmicos SHR
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA